Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
-Evaluate the efficacy and safety of Shenyankangfu Tablets to control the proteinuria of
patients with primary glomerulonephritis compare with Losartan potassium.